COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

We have a product basket of more than 30+ ready to offer APIs with DMF & other regulatory filings across CNS, CVS, Anti-infective, Anti-diabetic segments to name a few. We also have 10 molecules in the pipeline.

To help you find the generic API you require, we've listed our generic API product range below. You can also use our 'Find an API' search tool to get quick access to the information you need.

Our range of Developed Peptide API products
Product Name Category Name CAS NO US-DMF CEP
Buserelin acetate Peptide 68630-75-1 CEP Approved
Calcitonin Salmon acetate Peptide 47931-85-1 CEP Approved
Carbetocin acetate Peptide 37025-55-1 ASMF
Cetrorelix acetate Peptide 145672-81-7 34552 ASMF
Desmopressin acetate Peptide 62288-83-9 22871
Gonadorelin acetate Peptide 499785-55-6
Gonadorelin diacetate* Peptide 33515-09-2
Goserelin acetate Peptide 145781-92-6
Leuprolide acetate Peptide 74381-53-6 25128 CEP Approved
Octreotide acetate Peptide 79517-01-4
Oxytocin acetate Peptide 50-56-6 26517 CEP Approved
Terlipressin acetate Peptide 14636-12-5 CEP Approved
Tetracosactide acetate Peptide 16960-16-0
Vasopressin acetate Peptide 113-79-1 32146
CEP Approved CEP Approved
CEP Applied CEP Applied

Disclaimer

Piramal Enterprises Limited (Company) does not offer or supply for commercial use, Products protected under valid patents,where the sale of such products constitutes a patent infringement. Only research & development quantities of such products are manufactured and offered for the purpose of regulatory submissions in India and/or other jurisdiction, wherever such regulatory exemptions exist, according to Section 107A of the Indian Patent Act and the corresponding provision of the Patent Act of the respective jurisdiction. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Piramal makes no warranty as to the completeness or accuracy of the information provided herein. Furthermore, no information in this catalogue - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. In particular, nothing in this catalogue should be construed as a promotion or advertisement for any product, or for the use of any product, that infringes valid patents and/or is not authorized by the laws and regulations of your country of residence.